Recombinant B-subunit/whole cell cholera vaccine

重组B亚单位/菌体霍乱疫苗（肠溶胶囊）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant B-subunit/whole cell cholera vaccine

Drug Alias NameRecombinant Oral Cholera rBS-WC VaccineOraVacs可唯适

ClassificationVaccines > Vaccine type > Univalent vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Biological material > Bacterial vaccine +[5]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsDiarrheaCholera

Global Approved IndicationsDiarrheaCholera

Approved Indications in ChinaDiarrheaCholera

Original Approved Country/TerritoryMainland China

Original Approved Date2003/11/24

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesShanghai United Cell Biotechnology Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai United Cell Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsDiarrheaCholera

Inactive IndicationsN/A

Other Information

ATC CodeJ07AE